Guangzhou Baiyunshan Financials
| GU5 Stock | EUR 2.14 0.04 1.90% |
Guangzhou |
Understanding current and past Guangzhou Baiyunshan Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Guangzhou Baiyunshan's financial statements are interrelated, with each one affecting the others. For example, an increase in Guangzhou Baiyunshan's assets may result in an increase in income on the income statement.
Guangzhou Baiyunshan Stock Summary
Guangzhou Baiyunshan competes with Merck, Takeda Pharmaceutical, HANSOH PHARMAC, Elanco Animal, and ASPEN PHARUNADR. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and chemical raw material intermediates in the Peoples Republic of China and internationally. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China. GUANG BAIY operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 25168 people.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | CNE100000387 |
| Business Address | 45 Sha Mian |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.gybys.com.cn |
| Phone | 86 20 6628 1218 |
| Currency | EUR - Euro |
You should never invest in Guangzhou Baiyunshan without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Guangzhou Stock, because this is throwing your money away. Analyzing the key information contained in Guangzhou Baiyunshan's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Guangzhou Baiyunshan Key Financial Ratios
There are many critical financial ratios that Guangzhou Baiyunshan's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Guangzhou Baiyunshan reports annually and quarterly.| Return On Equity | 0.13 | |||
| Return On Asset | 0.0356 | |||
| Beta | 0.7 | |||
| Z Score | 5.8 | |||
| Last Dividend Paid | 0.69 |
Guangzhou Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Guangzhou Baiyunshan's current stock value. Our valuation model uses many indicators to compare Guangzhou Baiyunshan value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Guangzhou Baiyunshan competition to find correlations between indicators driving Guangzhou Baiyunshan's intrinsic value. More Info.Guangzhou Baiyunshan Pharmaceutical is rated # 4 in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.28 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Guangzhou Baiyunshan Pharmaceutical is roughly 3.60 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Guangzhou Baiyunshan's earnings, one of the primary drivers of an investment's value.Guangzhou Baiyunshan Systematic Risk
Guangzhou Baiyunshan's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Guangzhou Baiyunshan volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Guangzhou Baiyunshan correlated with the market. If Beta is less than 0 Guangzhou Baiyunshan generally moves in the opposite direction as compared to the market. If Guangzhou Baiyunshan Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Guangzhou Baiyunshan is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Guangzhou Baiyunshan is generally in the same direction as the market. If Beta > 1 Guangzhou Baiyunshan moves generally in the same direction as, but more than the movement of the benchmark.
Guangzhou Baiyunshan December 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Guangzhou Baiyunshan help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Guangzhou Baiyunshan Pharmaceutical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Guangzhou Baiyunshan Pharmaceutical based on widely used predictive technical indicators. In general, we focus on analyzing Guangzhou Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Guangzhou Baiyunshan's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.5 | |||
| Information Ratio | 0.1683 | |||
| Maximum Drawdown | 24.31 | |||
| Value At Risk | (3.19) | |||
| Potential Upside | 5.0 |
Complementary Tools for Guangzhou Stock analysis
When running Guangzhou Baiyunshan's price analysis, check to measure Guangzhou Baiyunshan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guangzhou Baiyunshan is operating at the current time. Most of Guangzhou Baiyunshan's value examination focuses on studying past and present price action to predict the probability of Guangzhou Baiyunshan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guangzhou Baiyunshan's price. Additionally, you may evaluate how the addition of Guangzhou Baiyunshan to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |